Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Camille R Simoneau

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Science Translational Medicine|March 16, 2021
SARS-CoV-2 infection of human iPSC-derived cardiac cells reflects cytopathic features in hearts of patients with COVID-19Juan A Perez-Bermejo, Serah Kang, Sarah J Rockwood, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2022
Immediate myeloid depot for SARS-CoV-2 in the human lungMélia Magnen, Ran You, Arjun A Rao, et al.
Research Square|May 25, 2022
Immediate myeloid depot for SARS-CoV-2 in the human lungMélia Magnen, Ran You, Arjun A Rao, et al.
Mbio|November 8, 2023
Hepatitis C virus infects and perturbs liver stem cellsNathan L Meyers, Tal Ashuach, Danielle E Lyons, et al.
Biorxiv : the Preprint Server for Biology|August 19, 2022
NF-κB inhibitor alpha has a cross-variant role during SARS-CoV-2 infection in ACE2-overexpressing human airway organoidsCamille R Simoneau, Pei-Yi Chen, Galen K Xing, et al.
Cell Stem Cell|November 24, 2020
Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in MenRyan M Samuel, Homa Majd, Mikayla N Richter, et al.
Scientific Reports|July 3, 2024
NF-κB inhibitor alpha controls SARS-CoV-2 infection in ACE2-overexpressing human airway organoidsCamille R Simoneau, Pei-Yi Chen, Galen K Xing, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2022
Tropism of SARS-CoV-2 for human cortical astrocytesMadeline G Andrews, Tanzila Mukhtar, Ugomma C Eze, et al.
Science Advances|July 31, 2024
Immediate myeloid depot for SARS-CoV-2 in the human lungMélia Magnen, Ran You, Arjun A Rao, et al.
Medrxiv : the Preprint Server for Health Sciences|January 25, 2022
Limited Cross-Variant Immunity after Infection with the SARS-CoV-2 Omicron Variant Without VaccinationRahul K Suryawanshi, Irene P Chen, Tongcui Ma, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Science Translational Medicine|March 16, 2021
SARS-CoV-2 infection of human iPSC-derived cardiac cells reflects cytopathic features in hearts of patients with COVID-19Juan A Perez-Bermejo, Serah Kang, Sarah J Rockwood, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2022
Immediate myeloid depot for SARS-CoV-2 in the human lungMélia Magnen, Ran You, Arjun A Rao, et al.
Research Square|May 25, 2022
Immediate myeloid depot for SARS-CoV-2 in the human lungMélia Magnen, Ran You, Arjun A Rao, et al.
Mbio|November 8, 2023
Hepatitis C virus infects and perturbs liver stem cellsNathan L Meyers, Tal Ashuach, Danielle E Lyons, et al.
Biorxiv : the Preprint Server for Biology|August 19, 2022
NF-κB inhibitor alpha has a cross-variant role during SARS-CoV-2 infection in ACE2-overexpressing human airway organoidsCamille R Simoneau, Pei-Yi Chen, Galen K Xing, et al.
Cell Stem Cell|November 24, 2020
Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in MenRyan M Samuel, Homa Majd, Mikayla N Richter, et al.
Scientific Reports|July 3, 2024
NF-κB inhibitor alpha controls SARS-CoV-2 infection in ACE2-overexpressing human airway organoidsCamille R Simoneau, Pei-Yi Chen, Galen K Xing, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2022
Tropism of SARS-CoV-2 for human cortical astrocytesMadeline G Andrews, Tanzila Mukhtar, Ugomma C Eze, et al.
Science Advances|July 31, 2024
Immediate myeloid depot for SARS-CoV-2 in the human lungMélia Magnen, Ran You, Arjun A Rao, et al.
Medrxiv : the Preprint Server for Health Sciences|January 25, 2022
Limited Cross-Variant Immunity after Infection with the SARS-CoV-2 Omicron Variant Without VaccinationRahul K Suryawanshi, Irene P Chen, Tongcui Ma, et al.
Pageof 3